Optical molecular imaging product developer Advanced Research Technologies (ART) has filed a preliminary short form prospectus with the securities regulatory authorities in each of the provinces of Canada for a public offering of common shares.

ART intends to use the net proceeds of the sale for the commercialization, sale and distribution of its products and for the development of new products and applications, according to the Montreal-based ART.

The transaction is subject to the receipt of the regulatory and stock exchange approvals.

Securities may not be offered or sold in the United States in the absence of registration or pursuant to an exemption from registration.